Quantum Genomics S.A.
PAR: ALQGC.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mathieu Bigois
- Employees
- 3
- Headquarters
- Paris, France
- IPO year
- 2010
- Market cap
- €5.0M
- Website
- https://www.quantum-genomics.com
Loading ALQGC…
Loading profile data…Frequently asked questions about ALQGC
What does Quantum Genomics S.A. (ALQGC.PA) do?
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the trea...
Where does ALQGC.PA trade?
Quantum Genomics S.A. (ALQGC.PA) trades on the Euronext Paris.
What sector is ALQGC.PA in?
Quantum Genomics S.A. (ALQGC.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Quantum Genomics S.A.?
Mathieu Bigois is the chief executive officer of Quantum Genomics S.A. (ALQGC.PA).
Where is Quantum Genomics S.A. headquartered?
Quantum Genomics S.A. is headquartered in France.
Does ALQGC.PA pay a dividend?
Quantum Genomics S.A. (ALQGC.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALQGC.PA go public?
Quantum Genomics S.A. (ALQGC.PA) completed its initial public offering in 2010.